Good morning, everyone, and welcome back. We hope your weekend was relaxing and refreshing. Now, of course, the time has come to resume the routine of meetings and deadlines. And yes, we are coping by brewing the mandatory cup of stimulation - our flavor today is Mocha Nut Fudge - and we invite you to join us. Meanwhile, here are some tidbits to help you get in the groover. Hope your day goes well and see you soon...
Five Lessons From The Niaspan Study (Forbes)
GlaxoSmithKline Is Downgraded By Goldman Sachs (Associated Press)
More Children Dying After Vaccination In India (India Times)
JB Chem & Pharma To Hire 1,500 Medical Reps (The Economic Times)
Sanofi Diabetes Drug Cuts Blood Sugar & Weight In Study (Reuters)
No Workers, No Products: A Bleak Future For Renovo (Pharma Times)
FDA Approves Optimer Antibiotic For Hospital Infections (Associated Press)
Combining Paxil And Pravachol Can Raise Blood Sugar (Boston Globe)
Drug Prices Rise 30 Percent In Qatar After New Law (Pharma Times)
Amarin Adds Two Suppliers For Fish Oil-Based Drug (Reuters)
Doctors Rethink Prescribing Niaspan (Chicago Tribune)
Eleven People Admit To Selling Fake Avastin In Shanghai (English Eastday)
Lupin Expects To Launch 50 Products in 2012 (The Economic Times)
Bayer To Outsource MS Drug Production To Boehringer (Reuters)
EDITOR’S NOTE: Please check this post for updates throughout the morning
steaming coffee thx to dleggett on flickr
2 Comments
Number 8 Title should read Combining Paxil and Pravachol, NOT Plavix and Pravachol
GSK downgraded themselves from unethical and dishonest business practices.